loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Naloxegol, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Naloxegol

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 1354744-91-4, Nktr-118 oxalate, Naloxegol (oxalate), Naloxegol oxalate [usan], Az13337019 oxalate, Az-13337019 oxalate
    Molecular Formula
    C36H55NO15
    Molecular Weight
    741.8  g/mol
    InChI Key
    MNYIRXLCPODKLG-VUTNLTPYSA-N
    FDA UNII
    65I14TNM33
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid
    2.1.2 InChI
    InChI=1S/C34H53NO11.C2H2O4/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2;3-1(4)2(5)6/h3-5,28-29,32,36-37H,1,6-25H2,2H3;(H,3,4)(H,5,6)/t28-,29+,32-,33-,34+;/m0./s1
    2.1.3 InChI Key
    MNYIRXLCPODKLG-VUTNLTPYSA-N
    2.1.4 Canonical SMILES
    COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
    2.1.5 Isomeric SMILES
    COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    65I14TNM33
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 1354744-91-4

    2. Nktr-118 Oxalate

    3. Naloxegol (oxalate)

    4. Naloxegol Oxalate [usan]

    5. Az13337019 Oxalate

    6. Az-13337019 Oxalate

    7. 65i14tnm33

    8. Moventig

    9. (4r,4as,7s,7ar,12bs)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic Acid

    10. Naloxegol Oxalate (usan)

    11. Unii-65i14tnm33

    12. Movantik (tn)

    13. Moventig (tn)

    14. Nktr-118-oxalate

    15. Naloxegol Oxalate [mi]

    16. Naloxegol Oxalate(nktr-118)

    17. Chembl2219416

    18. Schembl20839999

    19. Hy-a0118a

    20. Dtxsid50159395

    21. Naloxegol Oxalate [who-dd]

    22. Akos030526444

    23. Cs-5349

    24. Naloxegol Oxalate [orange Book]

    25. Nktr-118;az-13337019 Oxalate

    26. Ac-36031

    27. Movantik Component Naloxegol Oxalate

    28. Az 13337019

    29. Naloxegol Oxalate Component Of Movantik

    30. D10375

    31. Q27263878

    32. 4,5.alpha.-epoxy-6.alpha.-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

    33. 4,5alpha-epoxy-6alpha-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

    34. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5.alpha.,6.alpha.)-, Ethanedioate (1:1)

    35. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5alpha,6alpha)-, Ethanedioate (1:1)

    2.4 Create Date
    2012-05-14
    3 Chemical and Physical Properties
    Molecular Weight 741.8 g/mol
    Molecular Formula C36H55NO15
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count16
    Rotatable Bond Count25
    Exact Mass741.35717005 g/mol
    Monoisotopic Mass741.35717005 g/mol
    Topological Polar Surface Area201 Ų
    Heavy Atom Count52
    Formal Charge0
    Complexity971
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).

    5 Pharmacology and Biochemistry
    5.1 FDA Pharmacological Classification
    5.1.1 Pharmacological Classes
    Opioid Antagonists [MoA]; Opioid Antagonist [EPC]
    5.2 ATC Code

    A06AH03

    Post Enquiry
    POST ENQUIRY